The GEne Therapy INnovation Training Network

Project Information

GET-IN

Grant agreement ID: 101119880

DOI

10.3030/101119880

EC signature date 5 July 2023

Start date 1 September 2023

End date 31 August 2027

Funded under

• Marie Skłodowska-Curie Actions (MSCA)

Total cost

No data

EU contribution

€ 2 615 796,00

Coordinated by

KATHOLIEKE UNIVERSITEIT LEUVEN
Belgium

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Websites, patent fillings, videos etc. (2)

GET-IN movie

Report on production of short video

Website

Project website

Other (1)

Recruitment pack

Information for applicants

Publications

Peer reviewed articles (10)

A hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the quantification of intracellular cystine and its application in cystinosis research

Author(s): Toon Verdonck, Roger Mora de la Serna, Patrick Augustijns, Rik Gijsbers, Deirdre Cabooter
Published in: Analytical and Bioanalytical Chemistry, 2026, ISSN 1618-2642
Publisher: Springer Science and Business Media LLC
DOI: 10.1007/S00216-026-06526-X

Advanced therapy medicinal products are coming of age: A pipeline analysis of the clinical trial landscape

Author(s): Michiel Vanhaeren, Rik Gijsbers, Walter Van Dyck, Isabelle Huys, Steven Simoens
Published in: Drug Discovery Today, Issue 30, 2026, ISSN 1359-6446
Publisher: Elsevier BV
DOI: 10.1016/J.DRUDIS.2025.104459

Ligand-modified rAAV6 vectors with nanoblades allow high-level gene knockin in HSPCs without compromising cell survival

Author(s): Alejandra Gutierrez-Guerrero, Séverine Périan, Aurélien Leray, Chiara Martinello, Maria Jimena Abrey Recalde, Caroline Costa, Cecilia Iglesias Herrero, Mohammed Bouzelha, Dimitri Alvarez-Dorta, Sébastien G. Gouin, Eduard Ayuso, Oumeya Adjali, Hildegard Büning, David Deniaud, Mathieu Mével, Els Verhoeyen
Published in: Molecular Therapy Nucleic Acids, Issue 36, 2025, ISSN 2162-2531
Publisher: Elsevier BV
DOI: 10.1016/J.OMTN.2025.102495

Baboon endogenous retrovirus (ERV) envelope pseudotyped lentiviral vectors outperform human ERV lentivectors for transduction of T, B, NK and HSPCs

Author(s): Séverine Périan, Eva Castellano, Caroline Costa, Chiara Martinello, Anne Galy, Gisèle Froment, Rimas Orentas, Antonio Valeri, Els Verhoeyen
Published in: Gene Therapy, 2026, ISSN 0969-7128
Publisher: Springer Science and Business Media LLC
DOI: 10.1038/S41434-025-00587-W

In vivo CAR T cell therapy against angioimmunoblastic T cell lymphoma

Author(s): Adrien Krug, Aymen Saidane, Chiara Martinello, Floriane Fusil, Alexander Michels, Christian J. Buchholz, Jean-Ehrland Ricci, Els Verhoeyen
Published in: Journal of Experimental & Clinical Cancer Research, Issue 43, 2024, ISSN 1756-9966
Publisher: Springer Science and Business Media LLC
DOI: 10.1186/s13046-024-03179-5

Cystic fibrosis at a glance: from disease mechanism to therapy

Author(s): Kasper Gryspeert, Laudonia L. Dipalo, Ana L. Da Silva Cunha, Mattijs Bulcaen, Marjolein M. Ensinck, Marianne S. Carlon
Published in: Trends in Molecular Medicine, Issue 31, 2025, ISSN 1471-4914
Publisher: Elsevier BV
DOI: 10.1016/J.MOLMED.2025.02.001

Combining conventional and adapter CAR T cells: An elegant solution to erase current CAR T cell limitations

Author(s): Chiara Martinello, Els Verhoeyen
Published in: Molecular Therapy, Issue 34, 2026, ISSN 1525-0016
Publisher: Elsevier BV
DOI: 10.1016/J.YMTHE.2025.12.052

An Isogenic Human Myoblast Cell Model for Cystinosis Myopathy Reveals Alteration of Key Myogenic Regulatory Proteins

Author(s): Louise Medaer, Roger Mora, Zhuoheng Zhou, Nefele Giarratana, Laura Yedigaryan, Rita La Rovere, Elena Levtchenko, Vincent Mouly, Els Verhoeyen, Sebastiaan Eeltink, Achim Treumann, Tim Vervliet, Maurilio Sampaolesi, Rik Gijsbers
Published in: Journal of Cachexia, Sarcopenia and Muscle, Issue 16, 2026, ISSN 2190-5991
Publisher: Wiley
DOI: 10.1002/JCSM.70116

Opportunities for Microphysiological Systems in Toxicity Testing of New Drug Modalities

Author(s): Tengku Ibrahim Maulana, Nienke R. Wevers, Theodora Kristoforus, Morgan Chandler, Henriette L. Lanz, Jos Joore, Paul Vulto, Remi Villenave, Stefan Kustermann, Peter Loskill, Kristin M. Bircsak
Published in: Annual Review of Pharmacology and Toxicology, Issue 65, 2025, ISSN 0362-1642
Publisher: Annual Reviews
DOI: 10.1146/ANNUREV-PHARMTOX-061724-080621

Trojan Horse-Like Vehicles for CRISPR-Cas Delivery: Engineering Extracellular Vesicles and Virus-Like Particles for Precision Gene Editing in Cystic Fibrosis

Author(s): Laudonia Lidia Dipalo, Jacob Giehm Mikkelsen, Rik Gijsbers, Marianne S. Carlon
Published in: Human Gene Therapy, Issue 36, 2025, ISSN 1043-0342
Publisher: Mary Ann Liebert Inc
DOI: 10.1089/HUM.2024.258

Other (2)

data set related to doi: 10.1002/jcsm.70116

Author(s): MORA DE LA SERNA, R., Medaer, L., Zhou, Z., Giarratana, N., Yedigaryan, L., LA ROVERE, R., Levtchenko, E., Mouly, V., Verhoeyen, E., Eeltink, S., Treumann, A., VERVLIET, T., SAMPAOLESI, M., GIJSBERS, R.
Publisher: KU Leuven RDR
DOI: 10.48804/TKKQZT

Additional file 1 of In vivo CAR T cell therapy against angioimmunoblastic T cell lymphoma

Author(s): Krug, Adrien; Saidane, Aymen; Martinello, Chiara; Fusil, Floriane; Michels, Alexander; Buchholz, Christian J.; Ricci, Jean-Ehrland; Verhoeyen, Els
Published in: 2024
DOI: 10.6084/M9.FIGSHARE.27019260